Pluristem Therapeutics PSTI Collaboration

Pluristem Therapeutics PSTI

Pluristem Therapeutics PSTI signs a massive collaboration deal. Also, the stock looks great....

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Guess Who Picked Nexvet Biopharma Plc. (NASDAQ:NVET)...
Guess Who Just Picked Up Egalet Corp. (NASDAQ:EGLT) ...
Here's Who Just Picked Up Heron Therapeutics Inc. (N...

Pluristem Therapeutics PSTI signs a massive collaboration deal. Also, the stock looks great. Take a look below.

Pluristem Therapeutics PSTI Company Summary

Company Name:  Pluristem Therapeutics Inc.

Ticker: PSTI

Exchange: NASDAQ

Website: https://www.pluristem.com/  

Pluristem Therapeutics Company Summary

Pluristem is pushing the boundaries of science and engineering to create cell-based products for commercial use. The Company’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation.

Moreover, pluristem Therapeutics’ sources its therapeutic cells from the placenta, an ethically accepted and potent source.

The Company’s manufacturing platform is a patented and validated state-of-the-art 3D cell expansion system. Pluristem’s method is uniquely accurate, cost-effective, and consistent from batch to batch.

Why did PSTI go up?

Jan. 10th 2021

Announced the launch of an innovative collaboration to develop, manufacture and commercialize cultured cell-based products for the food industry.

Therefore, the collaboration started with the incorporation of a new company (“NewCo”), that will receive exclusive, global, royalty bearing licensing rights to use Pluristem’s proprietary technology, intellectual property and knowhow, to be used in the field of cultured meat.

PSTI 3 Month Chart

Pluristem Therapeutics PSTI

PSTI 1 Day Chart

Pluristem Therapeutics PSTI

PSTI Technical Analysis

The $1.87 PPS for Pluristem Therapeutics PSTI is important before I would consider the trade. However, this stock is looking great! It gapped up big and pulled back for a minute and consolidated all day with a bullish lean.

Pluristem Therapeutics PSTI is possibly a winner, but I wouldn’t expect big things, probably sub 50% gains in the next few weeks.

Stay in the lopp :

HUMBL Inc (HMBL) Stock Finds $1 Support And M...

Earlier this year, the HUMBL Inc (OTCMKTS:HMBL) stock emerged as one of the major gainers from among penny stocks this year. In recent

Inspira Technologies IINN is Up, Why is That?...

Inspira Technologies IINN is up 31% after due to a massive

Here's Who Just Picked Up Green Dot Corp (NYS...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Green Dot Corp (NYSE:GDOT) reported that Harvest Capital Strategies has

related post

Skip to content